Helen Anaedo, M.D
Endocrinology, Diabetes & Metabolism Physician in Plainville, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Helen Anaedo, M.D reported a CMS MIPS final score of 84.5/100 - above the 83.1 national average - and filed 3,760 Medicare Part D claims in 2023.
- 84.5/100
- MIPS score · +1 vs avg
- 4K
- Part D claims, 2023
- 47%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Helen Anaedo, M.D's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
85 45th percentile higher than 45% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Helen Anaedo, M.D sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Helen Anaedo, M.D writes more Part D claims than 68% of them and scores higher on MIPS quality than 50% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Helen Anaedo, M.D. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Helen Anaedo, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 4 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Helen Anaedo, M.D?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Connecticut providers
Endocrinology, Diabetes & Metabolism Physician ranks #73 among Connecticut's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Connecticut provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Helen Anaedo, M.D's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 84.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 84.5/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
84.5/100 MIPS final score - 1.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Endocrinology, Diabetes & Metabolism Physician. Quality dim: 79.3. Cost dim: 59.6.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Helen Anaedo, M.D appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D credentials at 201 N MOUNTAIN RD, Plainville, CT, 06062, with a listed phone of (860) 229-8889. NPI 1164717021 was issued on 06/17/2011.
Medicare Part D records for calendar year 2023 show 3,760 prescription claims written by this provider, covering 540 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, split 47% brand-name and 47% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.5/100 for the 2023 performance year (Quality 79.3, Cost 59.6), compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1164717021 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D |
| Gender | Female |
| NPI Issued | 06/17/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Helen Anaedo, M.D's current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1164717021 is the unique 10-digit identifier CMS uses to link Anaedo across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Helen Anaedo, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Helen Anaedo, M.D is affiliated with 4 Medicare-billing facilities across 2 states, 1 of which carry a CMS Hospital overall star rating.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Helen Anaedo, M.D. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
Abbott Laboratories
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
47% brand-name claims vs 47% generic, on 3,760 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,022
- Total Day Supply
- 267,266
- Brand vs Generic
- 47% brand / 47% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $68K
Patient Demographics
- Average Patient Age
- 70.9 years
- Avg HCC Risk Score
- 1.57
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 91, 65-74: 270, 75-84: 149, 85+: 30
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Helen Anaedo, M.D prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
440 claims
- Ozempic
Ozempic
229 claims
- Jardiance
Jardiance
181 claims
- Trulicity 154
Trulicity
154 claims
- Metformin Hcl Er 143
Metformin Hcl Er
143 claims
- Synthroid 131
Synthroid
131 claims
- Metformin Hcl 111
Metformin Hcl
111 claims
- Glipizide Er 104
Glipizide Er
104 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 440 |
| Ozempic Semaglutide | 229 |
| Jardiance Empagliflozin | 181 |
| Trulicity Dulaglutide | 154 |
| Metformin Hcl Er Metformin Hcl | 143 |
| Synthroid Levothyroxine Sodium | 131 |
| Metformin Hcl | 111 |
| Glipizide Er Glipizide | 104 |
| Atorvastatin Calcium | 96 |
| Alendronate Sodium | 84 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How Helen Anaedo, M.D fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
Helen Anaedo, M.D's 3,760 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Anaedo.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is Helen Anaedo, M.D's specialty? ▼
How much does Helen Anaedo, M.D prescribe under Medicare Part D? ▼
What is Helen Anaedo, M.D's Medicare quality score? ▼
Where is Helen Anaedo, M.D located? ▼
What is Helen Anaedo, M.D's NPI number? ▼
Does Helen Anaedo, M.D prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does Helen Anaedo, M.D prescribe most often? ▼
Does Helen Anaedo, M.D accept Medicare? ▼
How can I verify Helen Anaedo, M.D's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology